ID
42549
Description
Study ID: 110921 Clinical Study ID: 110921 Study Title: A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00811733 Clinicaltrials.gov Link: https://clinicaltrials.gov/ct2/show/NCT00811733 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Ofatumumab Trade Name: N/A Study Indication: Waldenstrom Macroglobulinaemia The primary objective of this open-label, multi-center, Phase II study was to evaluate the safety and efficacy of Ofatumumab in subjects diagnosed with Waldenstrom Macroglobulinaemia. For the study, eligible subjects were enrolled to receive up to 3 cycles of treatment with Ofatumumab. The first cycle consisted of a single dose of 300 mg followed by 3 weekly doses of 1000 mg (Treatment Group A) or 4 weekly doses of 2000 mg (Treatment Group B) of Ofatumumab, with response assessment beginning at Week 12. Based on the Week 12-16 response, eligible subjects could receive up to 2 additional cycles of treatment. This form has to be filled whenever/if additional scans have to be done during study.
Link
https://clinicaltrials.gov/ct2/show/NCT00811733
Keywords
Versions (1)
- 8/25/21 8/25/21 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 25, 2021
DOI
To request one please log in.
License
Creative Commons BY-NC 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ofatumumab in Waldenstrom Macroglobulinaemia, NCT00811733
Additional Scan
- StudyEvent: ODM
Description
Other protocol specified and/or additional scan
Alias
- UMLS CUI-1
- C2348563
- UMLS CUI-2
- C0011923
- UMLS CUI-3
- C0205394
- UMLS CUI-4
- C1524062
Description
Scan Method
Data type
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C0871511
Description
Date of Scan
Data type
date
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C0011008
Description
Anatomic location of image coverage
Data type
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1515974
Description
Other anatomic location of image coverage
Data type
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1515974
- UMLS CUI [1,3]
- C0205394
Description
Reminder: Any new lesions identified need to be indicated on the Response form and the details of the new lesions need to be entered onto the New Lesion form.
Data type
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C3146298
Description
Reminder: Any new lesions identified need to be indicated on the Response form and the details of the new lesions need to be entered onto the New Lesion form.
Data type
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C3146298
- UMLS CUI [1,3]
- C0205394
Description
If the result of the scan is unequivocal progression, ensure the Response Assessment form is completed.
Data type
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1274040
Description
If the result of the scan is unequivocal progression, ensure the Response Assessment form is completed.
Data type
text
Alias
- UMLS CUI [1,1]
- C0011923
- UMLS CUI [1,2]
- C1274040
- UMLS CUI [1,3]
- C1629507
Similar models
Additional Scan
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0011923 (UMLS CUI-2)
C0205394 (UMLS CUI-3)
C1524062 (UMLS CUI-4)
C0011008 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])
C1515974 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C3146298 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C1274040 (UMLS CUI [1,2])
C1629507 (UMLS CUI [1,3])
No comments